We bring together talent and expertise from across the University of Minnesota to use stem cell biology to advance regenerative medicine therapies for devastating disorders and to provide education and training for the stem cell scientists of tomorrow.
We depend on the variety of knowledge and expertise from faculty and departments across the University and beyond to pursue the collaborative goal of using stem cell technology to change the practice of regenerative medicine.
SCI scientists are making progress in finding treatments for spine and brain injury, heart damage, vision loss, diabetes, genetic disorders, cancer, and the need for organ and skin replacement.
Our Education Programs
The bioscience and medical industries and academic research programs need intelligent, engaged, well-trained talent to fill jobs in the rapidly expanding field of regenerative medicine. The Stem Cell Institute prepares students who are ready to meet this need and who are eager to move the next generation of research forward. Learn more about our graduate programs:
As in the US, unproven stem cell therapies have been marketed in Australia. Last week, the Therapeutic Goods Administration (TGA, similar to US FDA) of the Australian Government tightened regulations around advertising autologous (self) human cell and tissue products. As of July 1, 2018, these products cannot be marketed to consumers, and adverse events must be reported to the TGA.
The SCI is hard at work educating the next generation and developing collaborations to move science forward.
The SCI Leadership Team continues to craft paths that enable UMN stem cell research outcomes to change the practice of medicine. Three budding efforts are highlighted in this issue.
- Chan SSK, Arpke RW, Filareto A, Xie N, Pappas MP, Penaloza JS, Perlingeiro RCR, Kyba M. Skeletal Muscle Stem Cells from PSC-Derived Teratomas Have Functional Regenerative Capacity. Cell Stem Cell. 2018; 23, 74-85.
Weekly Research Conference
Engineering Microenvironments for Cardiovascular Regeneration
Milica Radisic, PhD
Institute of Biomaterials and Biomedical Engineering
Department of Chemical Engineering and Applied Chemistry
University of Toronto
Toronto, Ontario, Canada
SCI Special Seminar: Pluripotent Stem Cell-Derived Myogenic Progenitors for the Treatment of Muscular Dystrophies: How Far Are We?
Rita Perlingeiro, PhD
Professor of Medicine
Lillehei Professor in Stem Cell and Regenerative Cardiovascular Medicine
Lillehei Heart Institute
University of Minnesota